Joseph Horrigan
Chief Tech/Sci/R&D Officer at AMO Pharma Ltd.
Profile
Joseph Horrigan is currently an Associate Professor at The University of North Carolina at Charlotte and the Chief Medical Officer at AMO Pharma Ltd.
He previously worked as the VP-Clinical Development & Medical Affairs at Neuren Pharmaceuticals Ltd.
He earned a doctorate degree from the University of Rochester.
Joseph Horrigan active positions
Companies | Position | Start |
---|---|---|
The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Former positions of Joseph Horrigan
Companies | Position | End |
---|---|---|
NEUREN PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Joseph Horrigan
Rochester Christian University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEUREN PHARMACEUTICALS LIMITED | Health Technology |
Private companies | 1 |
---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Joseph Horrigan